Drug malabsorption and resistant tuberculosis in HIV-infected patients.

Suppr

超能文献

作者信息

Patel K B, Belmonte R, Crowe H M

出版信息

N Engl J Med. 1995 Feb 2;332(5):336-7. doi: 10.1056/NEJM199502023320518.

DOI:10.1056/NEJM199502023320518

PMID:7816080

Abstract

摘要

相似文献

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

N Engl J Med. 1995 Feb 2;332(5):336-7. doi: 10.1056/NEJM199502023320518.

Malabsorption of antimycobacterial medications.

N Engl J Med. 1993 Oct 7;329(15):1122-3. doi: 10.1056/NEJM199310073291513.

Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy.

Int J Clin Pharmacol Res. 1999;19(3):65-71.

HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.

J Indian Med Assoc. 2009 May;107(5):281-2, 284-6.

[Pericarditis due to multidrug resistant Mycobacterium tuberculosis in an HIV infected patient: case report and review of literature].

Rev Chilena Infectol. 2009 Apr;26(2):156-61. Epub 2009 Jun 16.

Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.

Int J Tuberc Lung Dis. 1997 Aug;1(4):319-25.

[Infections with Mycobacterium tuberculosis and MOTT (Mycobacteria other than tuberculosis) in HIV infected and AIDS patients].

Wien Med Wochenschr. 1994;144(8-9):182-6.

First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.

Int J STD AIDS. 2009 Aug;20(8):566-70. doi: 10.1258/ijsa.2008.008379.

Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome.

AIDS. 2007 Jan 30;21(3):373-4. doi: 10.1097/QAD.0b013e328012b84d.

Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.

J Med Assoc Thai. 2007 May;90(5):884-8.

引用本文的文献

Population pharmacokinetics of bedaquiline: a systematic review.

Eur J Clin Pharmacol. 2025 Mar;81(3):347-363. doi: 10.1007/s00228-024-03788-1. Epub 2025 Jan 8.

Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up.

Turk J Med Sci. 2023 Jun;53(3):761-770. doi: 10.55730/1300-0144.5639. Epub 2023 Jun 19.

Towards Improved Management of Tuberculous Bloodstream Infections: Pharmacokinetic Considerations with Suggestions for Better Treatment Outcomes.

Antibiotics (Basel). 2022 Jul 5;11(7):895. doi: 10.3390/antibiotics11070895.

Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.

J Clin Pharmacol. 2022 Oct;62(10):1206-1214. doi: 10.1002/jcph.2068. Epub 2022 Jun 13.

Population pharmacokinetics of ethambutol in African children: a pooled analysis.

J Antimicrob Chemother. 2022 Jun 29;77(7):1949-1959. doi: 10.1093/jac/dkac127.

Status of drug resistant tuberculosis among patients attending a tuberculosis unit of West Bengal: A record based cross-sectional study.

J Family Med Prim Care. 2022 Jan;11(1):84-89. doi: 10.4103/jfmpc.jfmpc_576_21. Epub 2022 Jan 31.

Cathepsins and Their Endogenous Inhibitors in Host Defense During and HIV Infection.

Front Immunol. 2021 Aug 4;12:726984. doi: 10.3389/fimmu.2021.726984. eCollection 2021.

Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.

Antibiotics (Basel). 2021 Jun 18;10(6):739. doi: 10.3390/antibiotics10060739.

Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018.

Antimicrob Resist Infect Control. 2021 May 8;10(1):76. doi: 10.1186/s13756-021-00947-2.

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

Tuberc Respir Dis (Seoul). 2020 Jan;83(1):20-30. doi: 10.4046/trd.2019.0065.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验